• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Log in to your Inderes Free account to see all free content on this page.
Create account

Arcoma

8.94 SEK

+1.13 %

Less than 1K followers

ARCOMA

First North Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+1.13 %
+3.23 %
+3.00 %
+21.80 %
+24.86 %
-5.30 %
-8.78 %
-52.32 %
-32.88 %

Arcoma operates in the medical technology sector. The company is a developer and supplier of integrated digital X-ray systems. The company's products offer digital imaging technology combined with technically advanced mobile positioning systems. The products are sold through resellers and to a large proportion of OEM customers. Operations are found on a global level with sales primarily concentrated in Europe, Asia and North America. The head office is located in Växjö.

Read more
Market cap
127.92M SEK
Turnover
33.43K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
EPS and dividend
Financial calendar
20.8.
2026

Interim report Q2'26

22.10.
2026

Interim report Q3'26

All
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Press release4/24/2026, 2:16 PM

DNB Carnegie Access: Arcoma: Market turmoil delays recovery – Q1 review

Arcoma
Press release2/13/2026, 8:22 AM

DNB Carnegie Access: Arcoma: Going into 2026 with favourable comparables – Q4 review

Arcoma
Press release2/13/2026, 8:15 AM

DNB Carnegie Access: Arcoma - Q4 2025 - Rapportintervju

Arcoma

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Press release2/9/2026, 6:19 AM

DNB Carnegie Access: Arcoma: Awaiting a market recovery in Europe – Q4 preview

Arcoma
Press release10/24/2025, 6:02 AM

DNB Carnegie Access: Arcoma: Europe muted, business mix supports margins – Q3 review

Arcoma
Press release10/13/2025, 4:52 PM

DNB Carnegie Access: Arcoma: Sequential improvements but US uncertainty – Q3 preview

Arcoma
Press release8/25/2025, 8:10 AM

DNB Carnegie Access: Arcoma: Intervju - Intervju efter Q2 2025

Arcoma
Press release8/22/2025, 6:00 AM

DNB Carnegie Access: Arcoma: US remains muted, easier comparisons in H2 – Q2 review

Arcoma
Press release7/8/2025, 1:02 PM

DNB Carnegie Access: Arcoma: Directed share issue, US to remain muted – Q2 preview

Arcoma
Regulatory press release6/24/2025, 5:15 PM

Arcoma AB successfully completes directed share issue of SEK 11.0 million (~ EUR 1 million) (MAR)

Arcoma
Press release4/29/2025, 2:39 PM

Carnegie Access: Arcoma: Solid gross margin, North America revenue declines – Q1 review

Arcoma
Press release2/17/2025, 2:20 PM

Carnegie Access: Arcoma: Intervju - Avslutar 2024 med starka marginaler (rapportintervju Q4)

Arcoma
Press release2/14/2025, 7:48 AM

Carnegie Access: Arcoma: Margins expand, but Europe remains under pressure – Q4 review

Arcoma
Regulatory press release6/12/2023, 11:00 AM

Arcoma signs distribution agreement with Canon Korea Inc.

Arcoma
Regulatory press release5/3/2023, 8:20 PM

Arcoma AB has received certification according to MDR (MAR)

Arcoma
Regulatory press release4/26/2023, 8:45 AM

Arcoma receives order of 10 systems to Thailand

Arcoma
Regulatory press release9/26/2022, 11:00 AM

Arcoma wins tender of 10 million SEK to Czech Republic (MAR)

Arcoma
Regulatory press release8/24/2022, 8:00 AM

Arcoma receives order of 8 systems to Thailand (MAR)

Arcoma
Regulatory press release7/7/2022, 11:00 AM

Arcoma Precision i5 approved for sales in Singapore

Arcoma
Regulatory press release6/27/2022, 11:00 AM

Arcoma wins important procurement in Finland. (MAR)

Arcoma